Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 143 (2) , 199-204
- https://doi.org/10.1016/s0923-2494(92)80166-i
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Liposomes in cancer therapyAdvanced Drug Delivery Reviews, 1989
- Therapy for Osteosarcoma in Dogs With Intravenous Injection of Liposome-Encapsulated Muramyl TripeptideJNCI Journal of the National Cancer Institute, 1989
- Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptideCancer Immunology, Immunotherapy, 1989
- Targeting of immunomodulators to mononuclear phagocytes for therapy of cancerAdvanced Drug Delivery Reviews, 1988
- Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptideCancer Immunology, Immunotherapy, 1985
- Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-?-aminobutyryl-D-isoglutamineClinical & Experimental Metastasis, 1984
- Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.Journal of Clinical Investigation, 1983
- Synthetic immunostimulants derived from the bacterial cell wallJournal of Medicinal Chemistry, 1980
- Therapy of Spontaneous Metastases by Intravenous Injection of Liposomes Containing LymphokinesScience, 1980
- Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in miceInternational Journal of Cancer, 1980